Whether you’re trying to identify the underlying cause of phenotypic or pathogenic abnormalities, looking to develop new interventions, or discover novel biomarkers, Applied Biosystems solutions are where rare and inherited disease research comes together. We deliver the customized products and services, gold-standard technology, and unrivaled in-house expertise you need to go out and find the answers to genomics’ biggest questions.
In this webinar, Eleonora Maino from the Hospital for Sick Children discusses using CRISPR-Cas9 genome editing to model tandem duplication disorders, such as Duchenne muscular dystrophy and MECP2 duplication syndrome, and how a single-sgRNA approach can be used to correct duplication mutations and treat tandem duplication disorders.
For Research Use Only. Not for use in diagnostic precedures.